← back to search

Carlos D. Flombaum

Memorial Sloan Kettering Cancer Center · US
Area of research
Pathology and Forensic Medicine · Hematology
Research interest
Research interests include Chemotherapy-induced organ toxicity mitigation, Renal cell carcinoma treatment, Renal Diseases and Glomerulopathies, and Multiple Myeloma Research and Treatments.
h-index
26
citations
2,978
works
52
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Long–Term Renal Outcomes after Cisplatin Treatment
Clinical Journal of the American Society of Nephrology 2016cited by 251position: lastdoi
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
Leukemia 2012cited by 99position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elyn Riedel · New York University1 papers (2012–2012)Heather Landau · Weill Cornell Medicine1 papers (2012–2012)— · 1 papers (2012–2012)Michael Rosenzweig · City Of Hope National Medical Center1 papers (2012–2012)Swati Mehta · Lawson Health Research Institute1 papers (2016–2016)Raymond L. Comenzo · University of Pennsylvania1 papers (2012–2012)Elizabeth Hoover · Hospital Universitari Arnau de Vilanova1 papers (2012–2012)Edgar A. Jaimes · Memorial Sloan Kettering Cancer Center1 papers (2016–2016)Sheron Latcha · Memorial Sloan Kettering Cancer Center1 papers (2016–2016)Ilya Glezerman · Memorial Sloan Kettering Cancer Center1 papers (2016–2016)Matthew J. Maurer · Toyota Motor Corporation (Switzerland)1 papers (2012–2012)Hani Hassoun · San Francisco VA Medical Center1 papers (2012–2012)Sergio Giralt · CancerCare1 papers (2012–2012)— · 1 papers (2012–2012)Sujata Patil · Cerner (United States)1 papers (2016–2016)